A phase I trial to investigate a single oral dose of SCY-078 in healthy subjects

Trial Profile

A phase I trial to investigate a single oral dose of SCY-078 in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs SCY 078 (Primary)
  • Indications Aspergillosis; Candidiasis; Vulvovaginal candidiasis
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jun 2016 New trial record
    • 20 Jun 2016 Interim sub-analysis (n=24) from this trial were presented at ASM Microbe 2016, according to a Scynexis media release.
    • 20 Jun 2016 Interim sub-analysis (n=24) from this trial published in a Scynexis media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top